Pfizer Vaccine for COVID-19 rolls off production line

Pfizer Vaccine for COVID-19 rolls off production line

A coronavirus vaccine on track for the new year is rolling off the production line. US multinational pharmaceutical corporation Pfizer has manufactured hundreds of doses of the drug in Belgium.

Pfizer has released promising footage of a potential coronavirus vaccine rolling off the production line — as the drug giant aims to have 100 million doses ready by the end of the year.

However, Pfizer's CEO announced on Friday in the US, it cannot request emergency authorisation of its COVID-19 vaccine before the third week of November - and that's if everything goes well.

The promising images come as AstraZeneca, a vaccine company Australia is aligned with, signalled their own candidate could be approved and become available as soon as Christmas

A number of other pharmaceutical companies are seeing COVID-19 vaccines developed and distributed by the beginning of next year.

Another leading US contender, Moderna Inc, previously announced the earliest it could seek authorization of its own vaccine would be November 25.